Treatment of chronic heart failure in long-term care facilities: Implications of recent heart failure guidelines recommendations

Archives of Gerontology and Geriatrics

Volumn 37, Issue 2, 2003, Pages 131-137

  Ahmed, Ali ^a,b  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Chronic heart failure; Heart failure guidelines; Long term care

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT; SPIRONOLACTONE; VASODILATOR AGENT;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG CONTRAINDICATION; EVALUATION; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; LONG TERM CARE; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURVIVAL;

EID: 0042167597     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4943(03)00027-X     Document Type: Article

References (33)

1. Ahmed A. Clinical characteristics of nursing home residents hospitalized with heart failure. J. Am. Med. Dir. Assoc. 3:2002;310-313.
2. Ahmed, A., in press. Use of spironolactone in heart failure patients receiving angiotensin-converting enzyme inhibitors and beta blockers. J. Am. Coll. Card. (Letter to the Editor: in press).
3. Ahmed A., Sims R.V. Highlights of the national nursing home survey: 1995. Ann. Long-Term Care. 6:2000;62-67.
4. Ahmed A., Weaver M., Allman R.M., DeLong J.F., Aronow W.S. The quality of care of nursing home residents hospitalized with heart failure. J. Am. Geriatr. Soc. 50:2002;1831-1836.
5. Ahmed A., Roseman J.M., Duxbury A.S., Allman R.M., DeLong J.F. Correlates and outcomes of preserved left ventricular systolic function among older adults hospitalized with heart failure. Am. Heart J. 144:2002;365-372.
6. Ahmed A., Kiefe C.I., Allman R.M., Sims R.V., DeLong J.F. Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications. J. Am. Geriatr. Soc. 50:2002;1659-1666.
7. Bonow R.O., Udelson J.E. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management. Ann. Intern. Med. 117:1992;502-510.
8. CIBIS-II Investigators and Committees, 1999. The cardiac insufficiency bisoprolol study II (CIBIS-II): A randomised trial. Lancet 353, 9-13.
9. DeLong J., Allman R., Sherrill R., Schiesz N. A congestive heart failure project with measured improvement in care. Eval. Health Prof. 21:1998;472-486.
10. European Study Group on Diastolic Heart Failure, 1998. How to diagnose diastolic heart failure. Eur. Heart J. 19, 990-1003.
11. Garg R., Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE inhibitor trials. J. Am. Med. Assoc. 273:1995;1450-1456.
12. Gambassi, G., Forman, D.E., Lapane, K.L., Mor, V., Sgadari, A., Lipsitz, L.A., Bernabei, R., The SAGE Study Group, 2000. Management of heart failure among very old persons living in long-term care: has the voice of trials spread? Am. Heart J. 139, 85-93.
13. Hunt S.A., Baker D.W., Chin M.H., Cinquegrani M.P., Feldman A.M., Francis G.S., Ganiats T.G., Goldstein S., Gregoratos G., Jessup M.L., Noble R.J., Packer M., Silver M.A., Stevenson L.W., Gibbons R.J., Antman E.M., Alpert J.S., Faxon D.P., Fuster V., Gregoratos G., Jacobs A.K., Hiratzka L.F., Russell R.O., Smith S.C. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure). J. Am. Coll. Cardiol. 38:2001;2101-2113.
14. Johnson J., Beier M., Cohn E., George J.E., Irvine P.W., Lehman M.E., Levenson S., Mislan T., Smith J., Wells A. Heart Failure; Clinical Practice Guideline. 1996;American Medical Directors Association, Columbia, MD, USA.
15. Konstam, M., Dracup, K., Bottoroff, M., Brooks, N.H., Dacey, R.A., Dunbar, S.B., Jackson, A.B., Jessup M, Johnson, J.C., Jones, R.H., Luchi, R.J., Massie, B.M., Pitt, B., Rose, E.A., Rubin, L.J., Wright, R.F., 1994. Heart failure: evaluation and care of patients with left ventricular systolic dysfunction: clinical practice guideline. DOHSS publication 94-0612 vol. Agency for Healthcare Research and Quality (formerly known as Agency for Health Care Policy and Research).
16. Krumholz H.M., Wang Y., Parent E.M., Mockalis J., Petrillo M., Radford M.J. Quality of care for elderly patients hospitalized with heart failure. Arch. Intern. Med. 157:1997;2242-2247.
17. MERIT-HF Study Group, 1999. Effect of metoprolol CRXL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 353, 2001-2007.
18. NCHS (National Center for Health Statistics), 1998. National hospital discharge survey: annual summary, 1995. Vitals statistics series 13, no. 133. DHHS publication no. 98-1794. Hyattsville, MD.
19. Newman J., Ahmed O., Hyngstrom T., Peto R.R., Clark J.D., Margolies M.P., Silver A.C., Snow R., Di Nardi J., Dunne P.K. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. Arch. Intern. Med. 157:1997;1103-1108.
20. NIH (National Institutes of Health), 1996. Congestive heart failure in the United States: a new epidemic. Data facts sheets. National Heart, Lung, and Blood Institute, Bethesda, MD.
21. NYHA (New York Heart Association) Criteria Committee, 1994. Nomenclature and Diagnosis of Disease of Heart and Great Vessels. ninth ed., Little Brown Co.: New York.
22. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N. Engl. J. Med. 334:1996;1349-1355.
23. Philbin E.F., Santella R.N., Rocco T.A. Jr. Angiotensin-converting enzyme inhibitor use in older patients with heart failure and renal dysfunction. J. Am. Geriatr. Soc. 47:1999;302-308.
24. Pitt B., Segal R., Martinez F.A., Meurers G., Cowley A.J., Thomas I., Deedwania P.C., Ney D.E., Snavely D.B., Chang P.I. Randomised trial of losartan versus captopril in patients over 65 with heart failure (evaluation of losartan in the elderly study, elite). Lancet. 349:1997;747-752.
25. Pitt B., Zannad F., Remme W.J., Cody R., Castaigne A., Perey A., Palensky J., Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N. Engl. J. Med. 341:1999;709-717.
26. Remme W.J., Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur. Heart J. 22:2001;1527-1560.
27. Rich M.W. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J. Am. Geriatr. Soc. 45:1997;968-974.
28. Stafford R.S., Saglam D., Blumenthal D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. Arch. Intern. Med. 157:1997;2460-2464.
29. The Consensus Trial Study Group, 1987. Effects of enalapril on mortality in severe congestive heart failure. Results of the cooperative North Scandinavian enalapril survival study (CONSENSUS). N. Engl. J. Med. 316, 1429-1435.
30. The SOLVD Investigators. 1991. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N. Engl. J. Med. 325, 293-302.
31. Vasan R.S., Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation. 101:2000;2118-2121.
32. Vasan R.S., Benjamin E.J., Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J. Am. Coll. Cardiol. 26:1995;1565-1574.
33. Williams J., Bristow M., Fowler M., Francis M.B., Garson A., Gersh B.J., Hammer D.F., Hlatky M.A., Leier C.V., Packer M., Pitt B., Ullyot D.J., Wexler L.F., Winters W.L. Guidelines for the evaluation and management of heart failure: Report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 92:1995;2764-2784.